ATE420081T1 - Trifluormethylbenzamidderivate und therapeutische verwendungen dafür - Google Patents
Trifluormethylbenzamidderivate und therapeutische verwendungen dafürInfo
- Publication number
- ATE420081T1 ATE420081T1 AT06706976T AT06706976T ATE420081T1 AT E420081 T1 ATE420081 T1 AT E420081T1 AT 06706976 T AT06706976 T AT 06706976T AT 06706976 T AT06706976 T AT 06706976T AT E420081 T1 ATE420081 T1 AT E420081T1
- Authority
- AT
- Austria
- Prior art keywords
- trifluormethylbenzamide
- derivatives
- therapeutic uses
- therapeutic
- trifluormethylbenzamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0502479A FR2883000B1 (fr) | 2005-03-14 | 2005-03-14 | Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420081T1 true ATE420081T1 (de) | 2009-01-15 |
Family
ID=34981603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06706976T ATE420081T1 (de) | 2005-03-14 | 2006-02-16 | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7947675B2 (de) |
| EP (1) | EP1858867B1 (de) |
| JP (1) | JP5042987B2 (de) |
| AR (1) | AR053340A1 (de) |
| AT (1) | ATE420081T1 (de) |
| AU (1) | AU2006224853B2 (de) |
| CA (1) | CA2600904C (de) |
| DE (1) | DE602006004713D1 (de) |
| ES (1) | ES2317496T3 (de) |
| FR (1) | FR2883000B1 (de) |
| WO (1) | WO2006097169A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
| US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| CN102482312A (zh) | 2009-08-26 | 2012-05-30 | 赛诺菲 | 新颖的杂芳族氟代糖苷结晶水合物、含有这些化合物的药物和它们的用途 |
| WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207671B1 (en) * | 1996-07-08 | 2001-03-27 | Bayer Aktiengesellschaft | Cycloalkano-pyridines |
| HRP970330B1 (en) * | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
| JP2006502247A (ja) * | 2002-07-12 | 2006-01-19 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 複素環で置換されたベンゾイル尿素、その製造方法および医薬としてのその使用 |
| UA79300C2 (en) * | 2002-08-12 | 2007-06-11 | Janssen Pharmaceutica Nv | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
-
2005
- 2005-03-14 FR FR0502479A patent/FR2883000B1/fr not_active Expired - Fee Related
-
2006
- 2006-02-16 ES ES06706976T patent/ES2317496T3/es active Active
- 2006-02-16 US US11/908,712 patent/US7947675B2/en not_active Expired - Fee Related
- 2006-02-16 JP JP2008501173A patent/JP5042987B2/ja not_active Expired - Fee Related
- 2006-02-16 AT AT06706976T patent/ATE420081T1/de not_active IP Right Cessation
- 2006-02-16 WO PCT/EP2006/001374 patent/WO2006097169A1/en not_active Application Discontinuation
- 2006-02-16 DE DE602006004713T patent/DE602006004713D1/de active Active
- 2006-02-16 CA CA2600904A patent/CA2600904C/en not_active Expired - Fee Related
- 2006-02-16 AU AU2006224853A patent/AU2006224853B2/en not_active Ceased
- 2006-02-16 EP EP06706976A patent/EP1858867B1/de not_active Not-in-force
- 2006-03-14 AR ARP060100959A patent/AR053340A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2883000A1 (fr) | 2006-09-15 |
| CA2600904C (en) | 2013-12-10 |
| CA2600904A1 (en) | 2006-09-21 |
| US7947675B2 (en) | 2011-05-24 |
| US20080119459A1 (en) | 2008-05-22 |
| JP5042987B2 (ja) | 2012-10-03 |
| AU2006224853B2 (en) | 2011-08-18 |
| WO2006097169A1 (en) | 2006-09-21 |
| FR2883000B1 (fr) | 2007-06-01 |
| AU2006224853A1 (en) | 2006-09-21 |
| AR053340A1 (es) | 2007-05-02 |
| EP1858867A1 (de) | 2007-11-28 |
| DE602006004713D1 (de) | 2009-02-26 |
| EP1858867B1 (de) | 2009-01-07 |
| JP2008537933A (ja) | 2008-10-02 |
| ES2317496T3 (es) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE420081T1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
| DE602006005539D1 (de) | Ernährungsschlauch und Schiene | |
| ATE525088T1 (de) | Kombinationstherapie | |
| DE602006001275D1 (de) | Gassack und Gassackeinrichtung | |
| CY2014030I1 (el) | Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate | |
| DK1928457T3 (da) | Quinoliner og deres terapeutiske anvendelse | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| DE602006011234D1 (de) | Airbag und Airbagvorrichtung | |
| ATE543825T1 (de) | Spiro-oxindolverbindungen und ihre verwendungen als therapeutische mittel | |
| PT1919894E (pt) | Novos derivados de poliquinolinas e a sua utilização terapêutica | |
| MA29039B1 (fr) | Dibenzylamines et derives | |
| DK1959991T3 (da) | Terapeutisk vaccine | |
| DE602006020061D1 (de) | Mucin-glycoprotein und anwendung davon | |
| DE602005009811D1 (de) | Tetrahydrocarbazole und derivate | |
| DE602006005104D1 (de) | Luftsack und Luftsackvorrichtung | |
| DE602005021918D1 (de) | Endloskörper und raupenvorrichtung | |
| DE602006002000D1 (de) | Gassack und Gassackeinrichtung | |
| DK1885716T3 (da) | Thiazolderivater og anvendelse deraf | |
| DE602006000563D1 (de) | Gassack und Gassackeinrichtung | |
| DE602008001981D1 (de) | Stellung und therapeutische verwendung | |
| DE602006017183D1 (de) | Benzimidazolderivat und anwendung davon | |
| DE602005020457D1 (de) | Master-slave-flip-flop, trigger-flip-flop und zähler | |
| DK1773829T3 (da) | Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf | |
| DE602006000612D1 (de) | Beidseitig tragbare Orthese | |
| DE112006002272T8 (de) | Katheter und Katheter-Kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |